Biotech

All Articles

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH possibility

.Novo Nordisk has axed its once-monthly dual GLP-1/ GIP receptor agonist, ending (PDF) advancement o...

Daiichi pays out Merck $170M to develop lung cancer cells T-cell engager deal

.Merck &amp Co. has swiftly recovered some of the costs of its own Spear Therapeutics buyout, drawin...

BioMarin standstills preclinical genetics therapy for heart disease

.After BioMarin administered a spring season clean of its pipeline in April, the provider has actual...

Eisai vegetations molecular glue SEED along with $1.5 B biobucks work

.Large Pharmas stay caught to the idea of molecular glue degraders. The most recent business to see ...

Life scientific research credit report organization reveals with $600M

.A new global life science credit report company, nicknamed Symbiotic Funding, has actually increase...

BMS trenches TIGIT, walking away from $200M bank on Agenus bispecific

.Bristol Myers Squibb is actually axing another major wager coming from the Caforio time, canceling ...

Nuvation stops BET inhibitor after thinking about period 1 record

.After taking a look at period 1 record, Nuvation Bio has determined to stop work with its single to...

' Professional intuition' led FDA advisors to back Zevra's unusual ailment med

.Zevra Therapies' unusual illness medication seems to be to become on the course to confirmation thi...

Pfizer takes $230M hit after axing neglected DMD genetics therapy

.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) gene therapy failure has actually gone a $230 thou...

AC Immune finds 'landmark' potential in Alzheimer's medicine data

.After more than 20 years of work on neurodegenerative illness, Swiss biotech air conditioner Immune...